Trial II of Lung Protection With Azithromycin in the Preterm Infant
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that administration of azithromycin to ventilated premature
infants will decrease the incidence and severity of BPD.
The purpose of this study is to determine if Azithromycin treatment is beneficial for
prevention of bronchopulmonary dysplasia in preterm infants.